Skip to main content

BioSolar Releases Company Update

SANTA CLARITA, Calif., Dec. 03, 2019 (GLOBE NEWSWIRE) — BioSolar, Inc. (OTCQB:BSRC)(“BioSolar” or the “Company”), a developer of breakthrough energy storage technology and materials, today provided an update from Chief Executive Officer Dr. David Lee, outlining corporate milestones of 2019, as well as next steps to establish longer term commercial viability.Selecting the 21700 cylindrical cell format for its commercial grade prototype cells, a decision made to clearly demonstrate the product’s commercial viability and achieve increased exposure for potential customers considering the Company’s additive technology. While lithium-ion battery packs based upon 18650 formatted cells have historically been popular, many end-users in high-growth industries believe the 21700 format cells will serve as the foundation for the battery of the future.Producing the first batch of domestically-produced materials that incorporate the Company’s proprietary performance-boosting silicon additive technology, before shipping to its international material manufacturing partner, a strategic procurement decision that the Company believes will ultimately drive down cost and improve quality control of the resulting product.Completing building and testing of its first batch of commercial grade prototype lithium-ion batteries. The initial results for the power and energy capabilities of the first batch of 21700 cells were much closer to meeting end-goal metrics than expected.Initiating preparation of the next batch of the commercial prototype development that incorporates additional 21700 cell design work to narrow the cell-to-cell capacity variation after cell formation. Narrower cell capacity distribution will allow consistent cell quality during manufacturing.There are a number of key objectives that BioSolar seeks to achieve moving forward in its quest to reach commercialization. They include:
Complete the next batch of the commercial prototype development that incorporates additional 21700 cell design work to successfully narrow the cell-to-cell capacity variation after cell formation. Once completed, the commercial grade prototype batteries will be sent to potential manufacturing and development partners for their own qualification testing and analysis.Continue working with existing technology development partners to build and demonstrate success for commercial grade Li-ion batteries incorporating the Company’s Si anode material and additive technologies.Commence a new technology development program targeting another specific industry vertical, a strategy designed to diversify application and establish the BioSolar’s longer term commercial viability in battery technology.Dr. Lee concluded, “While we have certain milestones to achieve and challenges to overcome, we are very optimistic about bringing BioSolar technologies to market in coming years. As high-growth industries continue to adopt new and improved lithium-ion battery technologies, the market opportunity is tremendous for a solution like ours, hopefully resulting in customer adoption and revenue generation.”About BioSolar, Inc.BioSolar is developing a breakthrough technology to increase the storage capacity, lower the cost and extend the life of lithium-ion batteries. A battery contains two major parts, a cathode and an anode, that function together as the positive and negative sides. BioSolar is currently investigating high capacity anode materials recognizing the fact that the overall battery capacity is determined by combination of both cathode and anode. By integrating BioSolar’s high capacity anode, battery manufacturers will be able to create a super lithium-ion battery that can double the range of a Tesla, power an iPhone for two days straight, or store daytime solar energy for nighttime use. Founded with the vision of developing breakthrough energy technologies, BioSolar’s previous successes include the world’s first UL approved bio-based back sheet for use in solar panels.To learn more about BioSolar, please visit our website at http://www.biosolar.com.Safe Harbor StatementMatters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words “anticipate,” “believe,” “estimate,” “may,” “intend,” “expect” and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company with the United Stated Securities and Exchange Commission.Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.CONTACT INFORMATIONInvestor Relations Contact
Tom Becker 
BioSolar, Inc.
ir@biosolar.com
(877) 904-3733

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.